IMPORTANCE OF MICROCALCIFICATIONS IN MAMMOGRAPHIC DIFFERENTIATION OF THE INVASIVE DUCTAL BREAST CANCER AND OF THE DUCTAL CARCINOMA IN SITU
Sažetak
Abstract
Introduction: Microcalcifications represent a significan tand reliable sign of the presence of the malignant breast lesion.
Aim: The aim of the paper is to radiologically evaluate the type and distribution of suspicious microcalcifications in patients with invasive ductal carcinoma (IDC) and ductal carcinoma in situ (DCIS).
Material and Methods: Retrospective analysis includes the evaluation of the type and distribution of suspicious microcalcifications in patients with histologically verified malignant lesions: invasive ductal carcinoma (N1=40 pts.) and ductal carcinoma in situ (N2=40 pts.). Standardised mediolateral oblique and cranicaudal views were selected for the evaluation of the images taken onthe full-field digital mammograph (FFDM «Selenia», Institute of Oncology and Radiology of Serbia, Belgrade), on the dedicated workstation of the mammography unit, with the aid of the software for lesion evaluation.
Results: Eight patients with invasive ductal carcinoma (20%) had no suspicious microcalcifications, as opposed to the patients with ductal in situ carcinoma where all patients had suspicious microcalcifications (p<0.05). In the subgroup of patients with invasive ductal carcinoma, the most frequent type of microcalcifications included the fine pleomorphic calcifications (75%). In patients with ductal carcinoma in situ, amorphous (57.5%) and linear / branching microcalcifications were more frequent than other types (55%).
Conclusion: The results of this study show that the amorphous microcalcifications segmental distribution usually detected in the subgroup with DCIS, which coincides with published results. With acceptable sensitivity and specificity, amorphous microcalcifications and linear distribution segment represents a specific mammographic findings in the detection of DCIS.
Keywords: microcalcifications, invasive ductal carcinoma, ductal carcinoma in situ, mammography
Reference
Ishan Barman, Narahara Chari Dingari, Anushree Saha, et al. Application of Raman spectroscopy to identify microcalcifications and underlying breast lesions at stereotactic core needle biopsy. Cancer Res. 2013; 73: 3206–3215.
Byun J, Lee JE, Cha ES, Chung J, Kim JH. Visualization of Breast Microcalcifications on Digital Breast Tomosynthesis and 2-Dimensional Digital Mammography Using Specimens. Breast Cancer (Auckl). 2017 Apr 12;11:1178223417703388
Chen-Pin Chou, Nan-Chieh Huang, Shu-Jhen Jhuang, et al. Ubiquitin-Conjugating Enzyme UBE2C Is Highly Expressed in Breast Microcalcification Lesions. PLoS One. 2014; 9: e93934.
Farshid G, Sullivan T, Downey P, Gill PG, Pieterse S. Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases. Br J Cancer. 2011 Nov 22;105:1669-75.
Nothacker M, Duda V, Hahn M, Warm M, Degenhardt F, Madjar H, et al. Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review. BMC Cancer. 2009 Sep 20;9:335.
Hashimoto Y, Murata A, Miyamoto N, Takamori T, Hosoda Y, Endo Y, et al. Clinical Significance of Microcalcifications Detection in Invasive Breast Carcinoma. Yonago Acta Med. 2015 Jun;58:89-93.
Chao-Jen Lai, Chris C. Shaw, Lingyun Chen, et al. Visibility of microcalcification in cone beam breast CT − Effects of x-ray tube voltage and radiation dose. Med Phys. 2007; 34: 2995–3004.
Galukande M, Kiguli-Malwadde E. Rethinking breast cancer screening strategies in resource-limited settings. Afr Health Sci. 2010;10:89–92.
Manuel Scimeca, Elena Giannini, Chiara Antonacci, Chiara Adriana Pistolese, Luigi Giusto Spagnoli, and Elena Bonanno. Microcalcifications in breast cancer: an active phenomenon mediated by epithelial cells with mesenchymal characteristics. BMC Cancer. 2014; 14: 286.
Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008 Feb 20;100:243-51.
Sue GR, Lannin DR, Killelea B, Chagpar AB. Predictors of microinvasion and its prognostic role in ductal carcinoma in situ. Am J Surg. 2013 Oct 206:478-81
Roses RE, Arun BK, Lari SA, et al. Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and death. Ann Surg Oncol. 2011;18:2873–8.
Rauch GM, Hobbs BP, Kuerer HM, Scoggins ME, Benveniste AP, Park YM et al. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence. Ann Surg Oncol. 2016 Feb;23:482-9.
Dinkel HP, Gassel AM, Tschammler A. Is the appearance of microcalcifications on mammography useful in predicting histological grade of malignancy in ductal cancer in situ? Br J Radiol. 2000 Sep;73:938-44.
Nadia P Castro, Cynthia ABT Osório, César Torres, et al. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res. 2008; 10: R87.
Szynglarewicz B, Kasprzak P, Biecek P, Halon A, Matkowski R. Screen-detected ductal carcinoma in situ found on stereotactic vacuum-assisted biopsy of suspicious microcalcifications without mass: radiological-histological correlation. Radiol Oncol. 2016 Apr 23;50:145-52.
Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G. et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94:1546–54.
Innos K, Horn-Ross PL. Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women. Cancer. 2003 Feb 15;97:1099-106.
Moelans CB, de Weger RA, Monsuur HN, Maes AH, van Diest PJ. Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study. Anal Cell Pathol (Amst). 2010; 33: 165-73.
Ying Zhong, Yan Lin, Songjie Shen, et al. Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse. Cancer Cell Int. 2013; 13: 60.
Carolina Sens-Abuázar, Elisa Napolitano e Ferreira, Cynthia Aparecida Bueno Toledo Osório, et al. Down-regulation of ANAPC13 and CLTCL1: Early Events in the Progression of Preinvasive Ductal Carcinoma of the Breast. Transl Oncol. 2012; 5: 113–123.
ACR BI-RADS Atlas Fifth Edition – Quick reference, (accessed on 10thJanuary 2015).
René Aloísio da Costa Vieira, Gabriele Biller, Gilberto Uemura, Carlos Alberto Ruiz,and Maria Paula Curado. Breast cancer screening in developing countries.Clinics (Sao Paulo). 2017 Apr;72:244-253
Stewart BW, Kleihues P. World Cancer Report. World Health Organization; 2003.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
Institute of Public Health of Serbia “ Dr Milan Jovanović - Batut”.Center for prevention and control of noncommunicable diseases.Cancer incidence and mortality in central Serbia 2014.Cancer registry of central Serbia. Report No.16
Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78–93
Hitchintan Kaur, Shihong Mao, Seema Shah, et al. Next-Generation Sequencing: A powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ. Expert Rev Mol Diagn. 2013; 13: 151–165.
Kaltenbach B, Brandenbusch V, Möbus V, Mall G, Falk S, van den Bergh M, et al. A matrix of morphology and distribution of calcifications in the breast: Analysis of 849 vacuum-assisted biopsies. Eur J Radiol. 2017 Jan;86:221-226.
Willekens I, Van de Casteele E, Buls N, Temmermans F, Jansen B, Deklerck R. et al. High-resolution 3D micro-CT imaging of breast microcalcifications: a preliminary analysis. BMC Cancer. 2014 Jan 6;14:9.
Kim SY, Kim HY, Kim EK, Kim MJ, Moon HJ, Yoon JH. Evaluation of malignancy risk stratification of microcalcifications detected on mammography: a study based on the 5th edition of BI-RADS. Ann Surg Oncol. 2015 Sep;22:2895-901
Marnix A. de Roos, Bert van der Vegt, Jaap de Vries, Jelle Wesseling, and Geertruida H. de Bock. Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast. Ann Surg Oncol. 2007 Jul;14:2097-104.
D'Orsi CJ. Imaging for the diagnosis and management of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010; 41:214-217.
Uematsu T, Kasami M, Yuen S. Usefulness and limitations of the Japan Mammography Guidelines for the categorization of microcalcifications. Breast Cancer. 2008;15:291-7.
Hofvind S, Iversen BF, Eriksen L, Styr BM, Kjellevold K, Kurz KD. Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening. Acta Radiol. 2011 Jun 1;52:481-7.
Holland R., Hendriks JH. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol. 1994; 11:191-192.
Slanetz PJ, Giardino AA, Oyama T, et al. Mammographic appearance of ductal carcinoma in situ does not reliably predict histologic subtype. Breast J. 2001; 7: 417-421.